Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in KYNB held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 400K | $3.0M | 0.0% | 9.879% | 0.04% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 160K | $1.2M | +2.1% | 3.950% | 0.00% |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 89K | $675K | 0.0% | 2.208% | 0.00% |
| 4 | BlackRock, Inc. | 84K | $637K | 0.0% | 2.083% | 0.00% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 43K | $326K | -6.0% | 1.067% | 0.00% |
| 6 | HighTower Advisors, LLC | 40K | $300K | +0.0% | 0.982% | 0.00% |
| 7 | TWO SIGMA INVESTMENTS, LP | 40K | $298K | -20.2% | 0.976% | 0.00% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 27K | $204K | -1.5% | 0.669% | 0.00% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 24K | $182K | +0.7% | 0.595% | 0.00% |
| 10 | Birchview Capital, LP | 23K | $170K | 0.0% | 0.557% | 0.08% |
| 11 | STATE STREET CORP | 20K | $153K | 0.0% | 0.501% | 0.00% |
| 12 | UBS Group AG | 8K | $59K | -71.5% | 0.194% | 0.00% |
| 13 | GROUP ONE TRADING LLC | 4K | $33K | -1.9% | 0.109% | 0.00% |
| 14 | Vanguard Global Advisers, LLC | 1K | $11K | 0.0% | 0.035% | 0.00% |
| 15 | Tower Research Capital LLC (TRC) | 1K | $8K | +235.2% | 0.028% | 0.00% |
| 16 | Axiom Investment Management LLC | 704 | $5K | 0.0% | 0.017% | 0.00% |
| 17 | MORGAN STANLEY | 487 | $4K | -0.2% | 0.012% | 0.00% |
| 18 | HARBOUR INVESTMENTS, INC. | 200 | $2K | 0.0% | 0.005% | 0.00% |
| 19 | NATIONAL BANK OF CANADA /FI/ | 193 | $1K | 0.0% | 0.005% | 0.00% |
| 20 | OSAIC HOLDINGS, INC. | 182 | $1K | +1.1% | 0.005% | 0.00% |
| 21 | Nova Financial LLC | 160 | $1K | 0.0% | 0.004% | 0.00% |
| 22 | SBI Securities Co., Ltd. | 152 | $1K | 0.0% | 0.004% | 0.00% |
| 23 | ROYAL BANK OF CANADA | 138 | $1K | +0.7% | 0.003% | 0.00% |
| 24 | ACADIAN ASSET MANAGEMENT LLC | 106K | $795 | 0.0% | 2.608% | 0.00% |
| 25 | BNP PARIBAS FINANCIAL MARKETS | 46 | $347 | -8.0% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in KYNB β a direct measure of their conviction.
Filings activity in KYNB during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 29 | 15% | 26.88% | 0.89 pp | $7M | +5.7% |
| Q1 2026 | 34 | +3.0% | 27.77% | β | $7M | 39% |
| Q4 2025 | 33 | +0.0% | β | β | $11M | 29% |
| Q3 2025 | 33 | +22% | β | β | $16M | +233% |
| Q2 2025 | 27 | 52% | β | β | $5M | 47% |
| Q1 2025 | 56 | 19% | 1.16% | 0.12 pp | $9M | 47% |
| Q4 2024 | 69 | 2.8% | 1.28% | 145.63 pp | $17M | 99% |
| Q3 2024 | 71 | β | 146.91% | β | $1.48B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.
Quick answers to the most common questions about buying KYNB stock.
Based on Q2 2026 13F filings, institutional ownership of Kyntra Bio, Inc. stands at 26.9%, held across 29 reporting institutions.
ARMISTICE CAPITAL, LLC is the largest reported institutional holder of KYNB, with approximately 400,000 shares worth $0.00B as of Q2 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of KYNB, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for KYNB is 42 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
1 institutions opened new positions in KYNB during Q2 2026, while 5 fully exited. 24 added to existing positions and 2 trimmed.
KYNB institutional ownership fell by 0.89 percentage points quarter-over-quarter, with a net change of -5 holders.
The top 10 institutions account for 96.1% of all reported 13F value in KYNB, and the top 25 account for 100.0%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), CNSY (4.8%), NXTS (3.3%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.